Standard
Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384–390. / Smits, Mark M.; van Raalte, Daniel H.
In:
Diabetes Care, Vol. 46, No. 5, e120, 2023.
Research output: Contribution to journal › Comment/debate › Research
Harvard
Smits, MM & van Raalte, DH 2023, '
Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384–390',
Diabetes Care, vol. 46, no. 5, e120.
https://doi.org/10.2337/dc23-0134
APA
Smits, M. M., & van Raalte, D. H. (2023).
Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384–390.
Diabetes Care,
46(5), [e120].
https://doi.org/10.2337/dc23-0134
Vancouver
Smits MM, van Raalte DH.
Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384–390.
Diabetes Care. 2023;46(5). e120.
https://doi.org/10.2337/dc23-0134
Author
Smits, Mark M. ; van Raalte, Daniel H. / Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384–390. In: Diabetes Care. 2023 ; Vol. 46, No. 5.
Bibtex
@article{d8fa7a8bf907410f97f63832511e5e94,
title = "Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384–390",
author = "Smits, {Mark M.} and {van Raalte}, {Daniel H.}",
year = "2023",
doi = "10.2337/dc23-0134",
language = "English",
volume = "46",
journal = "Diabetes Care",
issn = "1935-5548",
publisher = "American Diabetes Association",
number = "5",
}
RIS
TY - JOUR
T1 - Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384–390
AU - Smits, Mark M.
AU - van Raalte, Daniel H.
PY - 2023
Y1 - 2023
UR - http://www.scopus.com/inward/record.url?scp=85159340030&partnerID=8YFLogxK
U2 - 10.2337/dc23-0134
DO - 10.2337/dc23-0134
M3 - Comment/debate
C2 - 37185688
AN - SCOPUS:85159340030
VL - 46
JO - Diabetes Care
JF - Diabetes Care
SN - 1935-5548
IS - 5
M1 - e120
ER -
